Autoimmune type 1 diabetes diagnosis

Autoimmune type 1 diabetes affects 15 per 100,000 people worldwide.1 It is an autoimmune disease with a progressive nature caused by the loss of insulin-producing cells.2


Learn how autoimmune type 1 diabetes works

Why is an early autoimmune type 1 diabetes diagnosis important?

Autoimmune type 1 diabetes can lead to a medical emergency when left untreated.3 Early detection of autoimmune type 1 diabetes reduces the chance of starting the journey with a medical emergency and provides a better way to be introduced to living with the condition.4 It puts you in the driving seat, giving you time to prepare for a life with autoimmune type 1 diabetes.

What are the diagnostic tests for autoimmune type 1 diabetes?

Autoimmune type 1 diabetes can cause a wide range of symptoms, including unexplained weight loss, frequent urination, and increased thirst and tiredness.3


These symptoms play an important role in the diagnosis of symptomatic type 1 diabetes patients, however, it’s also now possible to diagnose autoimmune type 1 diabetes before the onset of symptoms through screening.2


Tests used for a diagnosis of autoimmune type 1 diabetes include:

Glycated hemoglobin (HbA1c) test

The HbA1c test is the main test used to diagnose autoimmune type 1 diabetes.5 This test determines the average blood glucose levels of the past 3 months. An HbA1c level of or above 6.5% indicates autoimmune type 1 diabetes. People with autoimmune type 1 diabetes need to get familiar with their A1C level because regular HbA1c assessments are used to monitor the disease and adjust treatment when necessary.

Fasting blood glucose test

This autoimmune type 1 diabetes test measures blood glucose levels after at least 8 hours without food and drink except for water. A blood glucose value of 126 mg/dL or more in repeated fasting blood glucose tests indicates autoimmune type 1 diabetes.1

Oral glucose tolerance test

The oral glucose tolerance test assesses blood glucose before and after a medical glucose drink. A value of at least 200 mg/dL determined 2 hours after the drink is consumed points to autoimmune type 1 diabetes.1

Random blood glucose test

This type 1 diabetes test measures blood glucose when symptoms appear. Blood glucose levels determined at random with this test at or above 200 mg/dL are likely caused by autoimmune type 1 diabetes.1

Can autoimmune type 1 diabetes be detected early through screening?

In autoimmune type 1 diabetes, the body's immune cells produce antibodies mistakenly against the pancreas.2 These so-called autoantibodies can appear years before the first symptoms emerge.


The detection of these autoantibodies through screening allows doctors to identify people who have a higher chance of developing autoimmune type 1 diabetes.2 In particular, individuals with a relative with autoimmune type 1 diabetes have an increased likelihood of developing autoimmune type 1 diabetes and are recommended to be screened.1,6


Doctors also use screening for autoantibodies to confirm a suspected type 1 diabetes diagnosis, because high blood glucose levels alone are not enough for a firm type 1 diabetes diagnosis..7


However, screening may not always find autoantibodies - 90% of relatives of people with autoimmune type 1 diabetes will not show any detectable autoantibodies.4


Learn more about screening in T1D.

What is the average age for an autoimmune type 1 diabetes diagnosis?

Autoimmune type 1 diabetes can be detected years before a diagnosis is made. Currently, the most common age for an autoimmune type 1 diabetes diagnosis is between 12-14 years old.2 However, more than 50% of new type 1 diabetes cases are diagnosed in adults.8


Autoimmune type 1 diabetes can develop at any age. In most cases, type 1 diabetes autoantibodies are already detectable before the age of 6.9 To detect autoimmune type 1 diabetes as early as possible, screening for autoimmune type 1 diabetes should therefore be done in young children, ideally at the ages of 2 and 6.10

How late can autoimmune type 1 diabetes be diagnosed?

Autoimmune type 1 diabetes can be diagnosed at any stage of life, with a rising number of people diagnosed over the age of 50.2,11


Adult patients are often diagnosed at a late stage when symptoms emerge and sometimes become medical emergencies, such as diabetic ketoacidosis.2,4 Screening for autoimmune type 1 diabetes can help reduce the likelihood of these medical emergencies.4 In particular, people with a family history of autoimmune type 1 diabetes or other autoimmune diseases are recommended to be screened.6 However, the majority of individuals with autoimmune type 1 diabetes do not have a family history of the condition.


See a healthcare professional if you suspect that you or your child has autoimmune type 1 diabetes.


Learn more about screening of autoimmune type 1 diabetes.

Is misdiagnosis of type 1 diabetes possible?

A misdiagnosis is possible and mostly occurs in adults over 30 years old.7 Autoimmune type 1 diabetes and prediabetes cause similar high blood glucose levels, making it difficult to distinguish the two conditions at this stage.12


Autoimmune type 1 diabetes can also be wrongly diagnosed as type 2 diabetes, as both conditions cause similar symptoms.8,11


A doctor might do additional tests, like a simple blood test for C-peptide, to distinguish type 1 diabetes from type 2 diabetes.11 However, it’s rare for these to be done.

What happens after a new type 1 diabetes diagnosis?

It is normal to feel surprised or scared by a new type 1 diabetes diagnosis and to have a lot of questions. Your healthcare team is there to support you in managing diabetes and living a long, healthy life.

There is currently no cure for autoimmune type 1 diabetes, however, new treatments are constantly being developed, making it easier to manage the condition.



If screening has shown that you are in presymptomatic stages 1 or 2 of autoimmune type 1 diabetes, then you and your doctor will keep track of the progression of your condition by monitoring changes in blood glucose levels7,13 No insulin therapy is needed at this stage.


If you have symptomatic stage 3 autoimmune type 1 diabetes, you’ll need to take insulin every day via injection or a pump.7,14 Your blood glucose levels have to be monitored regularly with blood glucose meters or continuous glucose monitors, as well as regular HbA1c tests.7


In addition to insulin therapy, exercise, lifestyle changes, and support services can help you manage the disease and your well-being.7

References

  1. Lucier J, Mathias PM. Type 1 diabetes. In: StatPearls. StatPearls Publishing; 2024. Accessed December 6, 2024. https://www.ncbi.nlm.nih.gov/books/NBK507713/
  2. Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3(1):17016. doi:10.1038/nrdp.2017.16
  3. Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes - A clinical perspective. Point Care. 2017;16(1):37-40. doi:10.1097/POC.0000000000000125
  4. Sims EK, Besser REJ, Dayan C, et al. Screening for type 1 diabetes in the general population: A status report and perspective. Diabetes. 2022;71(4):610-623. doi:10.2337/dbi20-0054
  5. Alzahrani BA, Salamatullah HK, Alsharm FS, et al. The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocr Disord. 2023;23(1):24. doi:10.1186/s12902-023-01280-y
  6. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964-1974. doi:10.2337/dc15-1419
  7. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. doi:10.2337/dci21-0043
  8. Leslie RD, Evans-Molina C, Freund-Brown J, et al. Adult-onset type 1 diabetes: Current understanding and challenges. Diabetes Care. 2021;44(11):2449-2456. doi:10.2337/dc21-0770
  9. Greenbaum CJ. A key to T1D prevention: Screening and monitoring relatives as part of clinical care. Diabetes. 2021;70(5):1029-1037. doi:10.2337/db20-1112
  10. Ghalwash M, Dunne JL, Lundgren M, et al. Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2022;10(8):589-596. doi:10.1016/S2213-8587(22)00141-3
  11. Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018;6(2):122-129. doi:10.1016/S2213-8587(17)30362-5
  12. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of Medical Care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17-S38. doi:10.2337/dc22-S002
  13. Phillip M, Achenbach P, Addala A, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetologia. 2024;67(9):1731-1759. doi:10.1007/s00125-024-06205-5
  14. Akil AAS, Yassin E, Al-Maraghi A, Aliyev E, Al-Malki K, Fakhro KA. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. J Transl Med. 2021;19(1):137. doi:10.1186/s12967-021-02778-6


[Approval date] [Approval code]